Select Page

London/Berlin, UK/DE, 25 September 2018 – The Heath-I initiative by Handelsblatt and Germany’s largest public health insurance, the Techniker-Krankenkasse nominated Amiko Digital Health for this year’s Health-I Award among the top three companies that have the potential to revolutionize the German healthcare system. On the basis of scientific criteria developed by Prof. Roland Trill of the Flensburg University of Applied Sciences, the jury decided out of 160 applications for the best innovations and ideas for a connected, future-oriented healthcare system. The Health-i initiative aims to promote the digital transformation of healthcare and offers the best talents a stage to present themselves and their ideas.


About Amiko Digital Health

Founded in 2015, Amiko is growing to become a global provider of hardware-enabled digital medicines. Amiko’s first product is Respiro, a digital medicine offering that optimises respiratory therapies using the world’s most advanced smart inhalers.

Respiro has been used in clinical studies and over 20 commercial programs in Italy, the Netherlands, Portugal and Germany. The system delivered consistent improvements in treatment use and outcomes: 37% increase in controller medication adherence, 42% improvement in optimal inhaler technique, and a 67% reduction in rescue medication use. For more information, visit

About Handelsblatt

The Handelsblatt is the largest business and financial newspaper in the German language. Around 200 editors, correspondents and permanent staff around the globe ensure up-to-date, comprehensive and well-founded reporting.

About Techniker

The Techniker Krankenkasse is Germany’s largest statutory health insurance fund with around 10.9 million insured people. As a progressive healthcare provider, it specializes in promoting medical and technological innovation and making it accessible to the insured.

Corporate Headquarters

Piazzale Aquileja, 6,
20144, Milan, Italy

Amiko UK

Studio 3.1, Bank Studios,
Park Royal Road,
NW10 7LQ, London, England

Join Our Mailing List

Leave your email address and we'll let you know when we have big news.